• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

液体复苏策略:动物试验的系统评价

Fluid resuscitation strategies: a systematic review of animal trials.

作者信息

Mapstone James, Roberts Ian, Evans Phillip

机构信息

Public Health Medicine, Castle Point and Rochford Primary Care Trust, Rayleigh, Essex, United Kingdom.

出版信息

J Trauma. 2003 Sep;55(3):571-89. doi: 10.1097/01.TA.0000062968.69867.6F.

DOI:10.1097/01.TA.0000062968.69867.6F
PMID:14501908
Abstract

OBJECTIVES

Our objective was to systematically review randomized, controlled trials of fluid resuscitation in animal models of uncontrolled hemorrhage and to explore potential sources of heterogeneity.

METHODS

We conducted an electronic bibliographic search of published research, reviewed reference lists of included trials, and contacted authors about unpublished studies. We included all unconfounded, randomized, controlled trials of fluid resuscitation (timing, volume, or resuscitation targets) in animal models of uncontrolled hemorrhage. The outcome measure was mortality at the end of the scheduled follow-up period of the trial. Two reviewers independently applied the selection criteria to the trial reports. A third reviewer resolved disagreements.

RESULTS

Forty-four trials compared fluid versus no fluid resuscitation. There was marked heterogeneity in the effect of fluid resuscitation on the risk of death, much of which was explained by the hemorrhage model used. In aortic injury models, the adjusted relative risk of death with fluid resuscitation was 0.48 (95% confidence interval [CI], 0.33-0.71). In organ incision models, the adjusted relative risk of death was 0.76 (95% CI, 0.49-1.18). In tail resection models, the adjusted relative risk of death was 0.69 (95% CI, 0.38-1.25) if 50% or more was removed and 1.86 (95% CI, 1.13-3.07) if less than 50% was removed. In other vascular injury models, the adjusted relative risk of death with fluid resuscitation was 1.70 (95% CI, 1.01-2.85), respectively. Nine trials compared hypotensive versus normotensive resuscitation. The relative risk of death with hypotensive resuscitation was 0.37 (95% CI, 0.27-0.50).

CONCLUSION

Fluid resuscitation appears to reduce the risk of death in animal models of severe hemorrhage but increases the risk of death in those with less severe hemorrhage. Excessive fluid resuscitation could therefore be harmful in some situations. Hypotensive resuscitation reduced the risk of death in all the trials investigating it. An evaluation of the potential impact of hypotensive resuscitation in humans could now be warranted.

摘要

目的

我们的目的是系统评价在未控制出血动物模型中进行液体复苏的随机对照试验,并探究潜在的异质性来源。

方法

我们对已发表的研究进行了电子文献检索,查阅了纳入试验的参考文献列表,并就未发表的研究与作者进行了联系。我们纳入了所有在未控制出血动物模型中进行液体复苏(时机、容量或复苏目标)的无混杂因素的随机对照试验。结局指标为试验预定随访期结束时的死亡率。两名研究者独立将纳入标准应用于试验报告。第三名研究者解决分歧。

结果

44项试验比较了液体复苏与未进行液体复苏的情况。液体复苏对死亡风险的影响存在显著异质性,其中大部分可由所使用的出血模型解释。在主动脉损伤模型中,液体复苏的校正死亡相对风险为0.48(95%置信区间[CI],0.33 - 0.71)。在器官切开模型中,校正死亡相对风险为0.76(95%CI,0.49 - 1.18)。在尾部切除模型中,如果切除50%或更多,校正死亡相对风险为0.69(95%CI,0.38 - 1.25);如果切除少于50%,则为1.86(95%CI,1.13 - 3.07)。在其他血管损伤模型中,液体复苏的校正死亡相对风险分别为1.70(95%CI,1.01 - 2.85)。9项试验比较了低血压复苏与正常血压复苏。低血压复苏的死亡相对风险为0.37(95%CI,0.27 - 0.50)。

结论

液体复苏似乎可降低严重出血动物模型的死亡风险,但会增加出血程度较轻动物模型的死亡风险。因此,在某些情况下过度液体复苏可能有害。低血压复苏在所有研究其的试验中均降低了死亡风险。现在有必要评估低血压复苏对人类的潜在影响。

相似文献

1
Fluid resuscitation strategies: a systematic review of animal trials.液体复苏策略:动物试验的系统评价
J Trauma. 2003 Sep;55(3):571-89. doi: 10.1097/01.TA.0000062968.69867.6F.
2
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
3
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2003(3):CD000213. doi: 10.1002/14651858.CD000213.
4
Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure.职业性HIV暴露后的抗逆转录病毒暴露后预防(PEP)。
Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD002835. doi: 10.1002/14651858.CD002835.pub3.
5
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
6
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6.
7
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
8
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.不同的皮质类固醇药物和方案用于加速有早产风险的婴儿的胎儿肺成熟。
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD006764. doi: 10.1002/14651858.CD006764.pub4.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Home versus in-patient treatment for deep vein thrombosis.深静脉血栓形成的家庭治疗与住院治疗对比
Cochrane Database Syst Rev. 2018 Jan 9;1(1):CD003076. doi: 10.1002/14651858.CD003076.pub3.

引用本文的文献

1
Control of Haemorrhage in Orthopaedic Trauma.骨科创伤中的出血控制
J Clin Med. 2024 Jul 22;13(14):4260. doi: 10.3390/jcm13144260.
2
Hypertension during transfer is associated with poor outcomes in unstable patients with ruptured abdominal aortic aneurysm.在腹主动脉瘤破裂的不稳定患者转运过程中发生高血压与不良预后相关。
J Vasc Surg. 2024 Apr;79(4):755-762. doi: 10.1016/j.jvs.2023.11.044. Epub 2023 Nov 29.
3
Anti-inflammatory agents as modulators of the inflammation in adipose tissue: A systematic review.抗炎药物作为脂肪组织炎症的调节剂:系统评价。
PLoS One. 2022 Sep 1;17(9):e0273942. doi: 10.1371/journal.pone.0273942. eCollection 2022.
4
Editorial: Fluid Therapy in Animals: Physiologic Principles and Contemporary Fluid Resuscitation Considerations.社论:动物的液体疗法:生理原理与当代液体复苏考量
Front Vet Sci. 2021 Oct 20;8:744080. doi: 10.3389/fvets.2021.744080. eCollection 2021.
5
Volume Resuscitation in the Acutely Hemorrhaging Patient: Historic Use to Current Applications.急性出血患者的容量复苏:从历史应用到当前应用
Front Vet Sci. 2021 Jul 29;8:638104. doi: 10.3389/fvets.2021.638104. eCollection 2021.
6
The Effects of Resuscitative Fluid Therapy on the Endothelial Surface Layer.复苏液体疗法对内皮表面层的影响。
Front Vet Sci. 2021 May 7;8:661660. doi: 10.3389/fvets.2021.661660. eCollection 2021.
7
Damage control resuscitation.损伤控制复苏
Clin Exp Emerg Med. 2020 Mar;7(1):5-13. doi: 10.15441/ceem.19.089. Epub 2020 Mar 31.
8
Can prospective systematic reviews of animal studies improve clinical translation?前瞻性动物研究系统评价能否改善临床转化?
J Transl Med. 2020 Jan 9;18(1):15. doi: 10.1186/s12967-019-02205-x.
9
Indices of muscle and liver dysfunction after surviving hemorrhage and prolonged hypotension.存活于出血和长时间低血压后出现的肌肉和肝功能障碍指标。
J Trauma Acute Care Surg. 2019 Jul;87(1S Suppl 1):S101-S109. doi: 10.1097/TA.0000000000002311.
10
What is the evidence base for fluid resuscitation in acute medicine? .急性医学中液体复苏的循证依据是什么?
Clin Med (Lond). 2018 Jun;18(3):225-230. doi: 10.7861/clinmedicine.18-3-225.